European stock markets rose to 4-month highs after Donald Trump's trade deal with the EU. Investors are cheering the easing of uncertainty, but some fear Brussels conceded too much, which could haunt ...

Goldman’s analysts also highlight perennial solar power issues such as demand-supply mismatches — the sun might not be shining when you actually need electricity, and storage remains an issue — and ...

US stocks rose Monday and the Dow was poised to hit its first record high of the year as investors welcomed the announcement ...

Here are the bull, bear, and base cases for the EV titan Tesla, as well as the varied viewpoints of multiple Wall Street pros ...

Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major ...

Goldman noted that the potential for renminbi appreciation, along with the emergence of DeepSeek and other AI models, has rekindled interest in China among many investors, though positioning among ...

Qube Research & Technologies is merging two of its largest hedge funds into one money pool with more than $20 billion in ...

Still, the rally is not without risks, given that the MSCI China Index has risen more than 25% so far this year. Goldman recommended focusing on individual stocks and raised its call on insurance and ...

Manual accounting may not show up as a line item, but it drains time, money and momentum in ways most SMBs overlook.

Individual joins following a 20-year tenure at the firm and succeeds the current interim chief executive, effective ...

Hedge funds fled technology stocks at the fastest pace in 12 months in the latest week, just as the S&P 500 reached all-time ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the top low volatility healthcare stocks to buy now. On July 24, Goldman Sachs analyst Asad Haider maintained a Hold rating on Bristol-Myers Squibb ...